Brachytherapy--radiation delivered close to or within a tumor--had its origins at the beginning of this century. Its use in prostate cancer was delayed first by the view that this was a relatively radioresistant cancer and then by clinical experience showing high failure and morbidity rates. More recently, technological innovations such as ultrasonography and computer-based treatment planning have made prostate brachytherapy a reasonable treatment option for many patients.
No takes yet. Share an insight, caveat, or question.
Garzotto et al. (2000) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: